Journals / Marmara Medical Journal / 2021 / Cilt: 34 - Sayı: 3

The natural course of gastric intestinal metaplasia in Turkish Patients: A single-center observational cohort study

Pages
229–233
Publication Date
2021-10-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further prospective studies in larger cohorts are required to enlighten the obscure strategies in the surveillanceof gastric malignancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gastric intestinal metaplasia (GIM) is considered as a predisposing lesion for the development of gastric cancer and isrecommended to be kept under surveillance in designated intervals.
📊
Key Findings & Data:We aimed to assess the natural course of GIM in a large Turkishcohort.Materials and Methods: We retrospectively reviewed findings from pathology reports of gastric biopsies conducted between 2011 to2018 to reveal patients diagnosed with solitary GIM in their index pathology report.
💡
Conclusion & Impact:Further prospective studies in larger cohorts are required to enlighten the obscure strategies in the surveillanceof gastric malignancy.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Gastric intestinal metaplasia · Gastric cancer · Dysplasia

Abstract

Objective: Gastric intestinal metaplasia (GIM) is considered as a predisposing lesion for the development of gastric cancer and isrecommended to be kept under surveillance in designated intervals. We aimed to assess the natural course of GIM in a large Turkishcohort.Materials and Methods: We retrospectively reviewed findings from pathology reports of gastric biopsies conducted between 2011 to2018 to reveal patients diagnosed with solitary GIM in their index pathology report. Progression of GIM was pre-defined as; lowgradedysplasia (LGD), high-grade dysplasia (HGD), or gastric malignancy.Results: The median follow-up period of the study population was 34 (12-128) months. Out of 109 patients with GIM at the entry, 54(49.6%) patients had stable GIM, whereas 53 (48.6%) cases had no signs of GIM at their final endoscopy. Only two (1.8%) patientsprogressed to LGD, but no HGD or malignancy was detected in the follow-up.Conclusion: Although, considered as a premalignant lesion and offered surveillance globally, progression of GIM was very low in alarge Turkish cohort. Further prospective studies in larger cohorts are required to enlighten the obscure strategies in the surveillanceof gastric malignancy.

🔖

Cite This Article

DEMIRTAS, C. O., KOLDAS, M., YILMAZ, M., SAHIN, M. Z., SOYKUVVET, M. T., CELIKEL, C. A., GUNDUZ, F. (2021). The natural course of gastric intestinal metaplasia in Turkish Patients: A single-center observational cohort study. Marmara Medical Journal, Cilt: 34 - Sayı: 3, 229–233. https://ajindex.com/articles/688287

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and management of gastric intestinal metaplasia: current status and future directions. Gut Liver 2019;13:596- 603. doi: 10.5009/gnl19181
  2. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology 2015;148:719-31 e3. doi: 10.1053/j.gastro.2015.01.040
  3. Zhu H, Xu H. Demographic and lifestyle risk factors for gastric intestinal metaplasia among US veterans. Am J Gastroenterol 2020;115:381-7. doi: 10.14309/ajg.0000000000000498
  4. Oh S, Kim N, Yoon H, et al. Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls. J Cancer Prev 2013;18:149-60. doi: 10.15430/jcp.2013.18.2.149
  5. Trieu JA, Bilal M, Saraireh H, Wang AY. Update on the diagnosis and management of gastric intestinal metaplasia in the USA. Dig Dis Sci 2019;64:1079-88. doi: 10.1007/s10620- 019-05526-5
  6. Yee YK, Wong KW, Hui CK, et al. Prevalence and time trend of intestinal metaplasia in Hong Kong. J Gastroenterol Hepatol 2009;24:896-9. doi: 10.1111/j.1440-1746.2009.05799.x
  7. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94. doi: 10.1001/jama.291.2.187
  8. Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The Prevalence of gastric intestinal metaplasia and distribution of helicobacter pylori infection, atrophy, dysplasia, and cancer in its subtypes. Gastroenterol Res Pract 2015;2015:434039. doi: 10.1155/2015/434039
  9. Choi AY, Strate LL, Fix MC, et al. Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population. Gastrointest Endosc 2018;87:1023-8. doi: 10.1016/j.gie.2017.11.010
  10. Song H, Ekheden IG, Zheng Z, Ericsson J, Nyren O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 2015;351:h3867. doi: 10.1136/bmj. h3867
  11. Liu KS, Wong IO, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016;22:1311-20. doi: 10.3748/wjg.v22. i3.1311
  12. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev 2015;20:25-40. doi: 10.15430/JCP.2015.20.1.25